Executives of the local research and development company Biosonics told shareholders yesterday that the company is pinning its immediate hopes to the success of an electronic device that can help people who have bowel control problems.
Food and Drug Administration approval of the Biosonics Anotron incontinence system paves the way for the company - which has spent more than $5 million developing new applications for electronics in medicine - to make the transition to manufacturing and marketing, according to chairman Jack Paller.
